NASDAQ · ACOGHealthcareBiotechnology

Alpha Cognition financials

$8.71+1.28%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
Revenue$10.2M$0.00
Gross profit$8.3M$0.00
Gross margin81.3%—
Operating income-$22.7M-$12.0M
Net income-$20.7M-$14.8M
Net margin−202.2%—
Diluted EPS$-1.18$-2.04
EBITDA-$22.6M-$11.9M
Operating cash flow-$20.4M-$7.8M
Free cash flow-$20.7M-$7.8M
Diluted shares17.7M7.2M

Balance sheet

Period endDec 31Dec 31
Cash & equivalents$66.0M$48.5M
Short-term investments$0.00$0.00
Total debt$0.00$0.00
Total assets$79.7M$50.7M
Total liabilities$17.2M$11.6M
Shareholders' equity$62.5M$39.1M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology